Anna Malara

Anna Malara

Auto-generated profile, based on publicly available information

Anna Malara

School of Medicine, University College Dublin, Dublin, Ireland

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 May 2020 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
JSJ. Sulaimani
J. Sulaimani
DCD. Cluxton
D. Cluxton
JCJ. Clowry
J. Clowry
APA. Petrasca
A. Petrasca
OMO.E. Molloy
O.E. Molloy
JFJ.M. Fletcher
J.M. Fletcher

1 May 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
JMJ. Musilova
J. Musilova
BMBarry Moran
Barry Moran
CSC.M. Sweeney
C.M. Sweeney
AMA. Malara
A. Malara
AZAlexandra M. Zaborowski
Alexandra M. Zaborowski
BKB. Kirby
B. Kirby

13 February 2023 in PLOS ONE
Verified
Journal Article
Open access
PDF file
APAndreea Petrasca
Andreea Petrasca
RHRoisin Hambly
Roisin Hambly
OMOonagh Molloy
Oonagh Molloy
SKSean Kearns
Sean Kearns
BMBarry Moran
Barry Moran
AMAnna Malara
Anna Malara
Hidradenitis suppurativa (HS) is a chronic relapsing inflammatory skin disease manifested as painful inflamed lesions including deep-seated nodules, abscesses and sinus tracts. The exact aetiology of HS is unclear. Recent evidence suggests that immune dysregulation plays a crucial role in pathogenesis and disease progression. Innate lymphoid cells (ILC) are a recently identified immune cell subset involved in mediating immunity, however their role in HS has not yet been investigated. Three distinct subsets of ILC- ILC1, ILC2 and ILC3 have been described, and these are involved in skin tissue homeostasis and pathologic inflammation associated with autoimmunity and allergic diseases. In this study, we analysed by multiparameter flow cytometry the frequencies of ILC subsets in skin and peripheral blood mononuclear cells (PBMC) of HS patients and compared these to healthy control subjects and psoriasis patients. The absolute numbers of total ILC and subsets thereof were significantly reduced in the blood of HS patients relative to healthy controls. However, when patients were stratified according to treatment, this reduction was no longer observed in patients undergoing anti-TNF treatment. In HS lesional skin the absolute numbers of ILC were significantly increased relative to control skin. Furthermore, the frequencies of total ILC as well as ILC2 and ILC3 were significantly higher in non-lesional than lesional HS skin. This study analysed for the first time the presence of ILC subsets in the blood and skin of HS patients. Our findings suggest that ILC may participate in HS pathogenesis.